Harper Investing’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
991
+202
+26% +$206K 0.4% 52
2026
Q1
$726K Buy
789
+595
+307% +$603K 0.32% 55
2025
Q4
$209K Buy
+194
New +$185K 0.09% 65

Other funds holding LLY

Harper Investing's LLY Position: Q2 2026 in Review

Harper Investing increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $206K and bringing the position to 991 shares worth $1.19M. The position accounts for 0.4% of the portfolio, ranked #52.

Harper Investing first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,814 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Harper Investing held 991 shares of Eli Lilly worth $1.19M as of Q2 2026.
  • Harper Investing bought 202 Eli Lilly shares in Q2 2026, an estimated $206K.
  • Eli Lilly made up 0.4% of Harper Investing's portfolio in Q2 2026, its #52 holding.
  • Harper Investing first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 1,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harper Investing's 13F filing for Q2 2026, filed 22 Jul 2026.